Bitcoin
Bitcoin needs to trade through 107,750 to re-establish the uptrend.

Bitcoin needs to trade through 107,750 to re-establish the uptrend.
Amcor Add to watchlist and wait for a close above the 10-day average.
Betashares Aus Equities Strong Bear Complex : The inverse ASX200 ETF trade is trending with the stop loss in place at $23.06
Ansell is under Algo Engine buy conditions.
Dimerix : Buy with a stop loss at $0.50
Dimerix Limited operates in the biotechnology industry, focusing on the development and commercialization of innovative therapies for unmet medical needs. The company is primarily engaged in creating pharmaceutical solutions that target specific diseases
Investor Summary – Dimerix Limited (ASX: DXB)
June 2025
Company Overview
Dimerix is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for inflammatory diseases, with a lead focus on kidney disorders. The company’s flagship asset, DMX-200, is in Phase 3 trials for Focal Segmental Glomerulosclerosis (FSGS), a rare and serious kidney disease with limited treatment options.
Lead Program: DMX-200 for FSGS
Market Opportunity
Strategic Partnering
Investment Highlights
✓ Global Phase 3 trial targeting rare disease with high unmet need
✓ Validated by multiple licensing transactions and regulatory alignment
✓ Strong IP protection with composition and use patents
✓ Experienced leadership team with a proven track record in biotech commercialization
✓ Pipeline expansion opportunities in broader inflammatory conditions
Leadership & Governance
Led by CEO Dr. Nina Webster, supported by a board and management team with decades of experience in drug development, commercialization, and strategic partnerships (ex-Pfizer, Roche, Mayne Pharma, etc.).
BHP Group is under Algo Engine buy conditions.
The S&P 500 is currently below the 10-day average, and overhead resistance is located at 6059, with a lower high stop-loss at 6004.
BBUS is the inverse ETF to consider.
ASX:MPAT Add to watchlist
Or start a free thirty day trial for our full service, which includes our ASX Research.